Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.2.1    Secondary

1.2.2    Primary

Chapter 2   Executive Summary

2.1    Asia Pacific clinical trial management system industry summary, 2016 – 2027

2.1.1    Country trends

2.1.2    Component trends

2.1.3    Product trends

2.1.4    Delivery mode trends

2.1.5    End-use trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2016 - 2027

3.3    Major factor analysis

3.3.1    Drivers

3.3.1.1    Outsourcing of clinical trials in emerging countries

3.3.1.2    Enhanced R&D expenditure of life science and clinical research industries

3.3.1.3    Increasing number of clinical trials

3.3.2    Industry pitfall and challenges

3.3.2.1    High cost of clinical trial management system

3.4    COVID-19 impact analysis

3.5    Porter’s analysis

3.6    Competitive review, 2020

3.7    PEST analysis

Chapter 4   Asia Pacific Clinical Trial Management System Market, By Component

4.1    Key trends in Asia Pacific clinical trial management system market, by component

4.2    Software

4.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.3    Services

4.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 5   Asia Pacific Clinical Trial Management System Market, By Product

5.1    Key trends in Asia Pacific clinical trial management system market, by product

5.2    Enterprise based

5.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.3    Site based

5.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 6   Asia Pacific Clinical Trial Management System Market, By Delivery Mode

6.1    Key trends in Asia Pacific clinical trial management system market, by delivery mode

6.2    Web based CTMS

6.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

6.3    Cloud based CTMS

6.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

6.4    On premise based CTMS

6.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 7   Asia Pacific Clinical Trial Management System Market, By End-use

7.1    Key trends in Asia Pacific clinical trial management system market, by end-use

7.2    Pharmaceutical and biopharmaceutical companies

7.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

7.3    Clinical research organization (CRO)

7.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

7.4    Others

7.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 8   Asia Pacific Clinical Trial Management System Market, By Country

8.1    Key trends in Asia Pacific clinical trial management system market, by country

8.2    China

8.2.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.2.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.2.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.2.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.3    Japan

8.3.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.3.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.3.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.3.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.4    India

8.4.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.4.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.4.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.4.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.5    South Korea

8.5.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.5.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.5.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.5.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.6    Taiwan

8.6.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.6.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.6.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.6.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.7    Australia

8.7.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.7.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.7.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.7.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.8    Thailand

8.8.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.8.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.8.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.8.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.9    New Zealand

8.9.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.9.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.9.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.9.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.10    Singapore

8.10.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.10.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.10.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.10.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

8.11    Malaysia

8.11.1    Market estimates and forecast, by component, 2016 – 2027 (USD Million)

8.11.2    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

8.11.3    Market estimates and forecast, by delivery mode, 2016 – 2027 (USD Million)

8.11.4    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

Chapter 9   Company Profiles

9.1    Bioclinica Inc

9.1.1    Business overview

9.1.2    Financial data

9.1.3    Product landscape

9.1.4    Strategic outlook

9.2    Bio-optronics

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.3    Datatrak Inc

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.4    DSG Inc

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.5    Advarra

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.6    Clinevo Technologies

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.7    Medidata Solution Inc

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.8    eResearch Technology Solutions

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.9    Merge Healthcare (IBM Watson)

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.10    Anju Software, Inc.

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.11    Oracle Corporation

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.12    Paraxel International

9.12.1    Business overview

9.12.2    Financial data

9.12.3    Product landscape

9.12.4    Strategic outlook

9.13    Veeva System

9.13.1    Business overview

9.13.2    Financial data

9.13.3    Product landscape

9.13.4    Strategic outlook